Equity Capital: 29.63 Cr FV: 10.00
| Period | MF Net Purchase / (sold) | FII Net |
|---|---|---|
| LAST 1M | 9,527.59 | 7,252.76 |
| LAST 3M | 42,415.10 | -9,114.21 |
| LAST 6M | 72,085.06 | 4,510.60 |
| LAST 12M | 156,258.18 | -37,934.40 |
| Date | Action Type | Ratio |
|---|---|---|
| No data found |
Godavari Drugs is engaged in manufacturing drugs. Sulphamethoxazole (SMX), the main product of the company, is a widely used anti-bacterial drug enjoying good export demand. The company has expanded its SMX capacity from 540 tpa to 720 tpa, integrating backward into the manufacture of drug intermediates, sulphamethoxide (cap.: 450 tpa) and diethyl oxalate, DEO (cap.: 750 tpa), and diversifying into the manufacture of trimetroprim, TMP (cap.: 144 tpa). The diversification into TMP is beneficial as SMX and TMP are used in combination to treat a wide variety of infections. The backward integration into SMO and DEO will enhance value-addition. In fact, Siris and Chemox Chemicals, both having good capacities of SMX, have recently gone in for the production of SMO. In 2000 the company introduced `Pyrazyamide` in the market. Since the product is being well accepted in the market the company is planning to increase the capacity of `Pyrazyamide` of 180 TPA and have also finalised on other products Cislactum,which is a intermediate used to produce Diltiazem an anti anginal drug.
Mayfair 1-8-303-34, Sardar Patel Road, Secunderabad, Andhra Pradesh, 500003
| Tel | : | 91-40-27849700/27844557 |
| : | info:godavaridrugs.com | |
| Website | : | http://www.godavaridrugs.com |
CIL Securities Limited
| AGM Date (Month) | : | Aug |
| Face Value Equity Shares | : | 10 |
| Market Lot Equity Shares | : | 1 |
| BSE Code | : | 530317 |
| NSE Code | : | |
| Book Closure Date (Month) | : | Aug |
| BSE Group | : | X |
| ISIN | : | INE362C01012 |
FAQ’s on Godavari Drugs Ltd SharesYou can buy Godavari Drugs Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Godavari Drugs Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Mar 21, 2023 04:01 PM the closing price of Godavari Drugs Ltd was ₹ 79.90.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Mar 21, 2023 04:01 PM, the market cap of Godavari Drugs Ltd stood at ₹ 60.17.
The latest PE ratio of Godavari Drugs Ltd as of Mar 21, 2023 04:01 PM is 15.91
The latest PB ratio of Godavari Drugs Ltd as of Mar 21, 2023 04:01 PM is 0.53
The 52-week high of Godavari Drugs Ltd is ₹ 102.00 while the 52-week low is ₹ 52.00
Invest
